Recent Trends in the Pathophysiology of Leptospirosis
A special issue of Tropical Medicine and Infectious Disease (ISSN 2414-6366).
Deadline for manuscript submissions: closed (23 April 2023) | Viewed by 1739
Special Issue Editors
2. Department of Neural Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA
Interests: infectious diseases; leptospirosis; molecular pathogenesis
Interests: infection and inflammation; mitochondrial biology; Ca2+ and Mg signaling; ion channels
Special Issue Information
Dear Colleagues,
Leptospirosis is an acute septicemic illness that affects humans and animals. It is caused by bacteria of the genus Leptospira. Humans contract leptospiral infection through direct contact with the blood, tissue organs, and urine of infected animals or through indirect contact by exposure to contaminated water, as leptospires are capable of penetrating through the injured mucosa or skin that confronts contaminated water bodies.
Without treatment, leptospirosis can lead to multiorgan failure and even death. The clinical manifestations of leptospirosis range from mild symptoms to severe forms of the disease with jaundice, acute kidney injury (AKI), cardiovascular manifestations, and pulmonary hemorrhages. The early phase of manifestation lasts 3–7 days with fever, headaches, myalgia, nausea, vomiting, malaise, and conjunctival hyperemia. This phase is known as a leptospiral blood bath because it widely circulates in the blood. Further, the severe form of the disease progresses to the second chronic phase, which lasts up to 30 days and initiates more complicated systemic impairments. AKI is one of the reported incidences of a severe form of leptospirosis, the kidney being the principal target organ of Leptospira. Interstitial nephritis is the major pathological alteration that occurs in patients with leptospirosis. Then, pulmonary hemorrhage top to acute respiratory distress syndrome (ARDS) occurs, and this establishes the most severe manifestation of lung injury. AKI and ARDS are consistently linked due to their association during leptospirosis, resulting in high fatality rates. Consequently, early identification of hemorrhage syndrome during leptospiral infection is crucial for faster management and a reduction in casualty rates. Apart from these, cardiac arrhythmias can also occur due to atrial fibrillation and atrioventricular blockage.
Thus, effective management strategies need a comprehensive understanding of the pathophysiology of leptospirosis. The disposal of the complete genome sequences of Leptospira interrogans applies to understanding the front-line mechanisms of the pathophysiology of leptospirosis. Injuries to the cell membrane are the reason for severe consequences to the host, such as loss of vascular integrity, ischemia, and necrosis, leading to significant organ dysfunctions. Then, understanding the molecular mechanisms involved in the pathogenesis and pathology of leptospirosis at a cellular level is of utmost importance for prognostic and therapeutic applications. This Special Issue invites research papers focused on understanding the pathophysiology of leptospirosis with native to contemporary developments to benefit case management in an effective way to reduce mortality.
Prof. Dr. Kalimuthusamy Natarajaseenivasan
Dr. Santhanam Shanmughapriya
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Tropical Medicine and Infectious Disease is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Leptospira interrogans
- leptospirosis
- pathogenesis
- pathology
- immune response
- biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.